Technology platforms mind the gap

As we look back on an incredible DCAT Week, we couldn't be more grateful for the chance to work alongside such a fantastic organisation and connect with our amazing clients and industry peers.

Our wrap-up video captures all the memorable moments, from engaging sessions to the vibrant energy at each event. I'm thrilled to be a media partner for such a meaningful event and can't wait to see where these connections take us in the future.

A huge thank you to everyone who made this week a success! We're excited to share our video recap and continue building on the inspiration we've gained together. Here's to driving innovation in our industry!

1 0

We recently had the opportunity to sit down with Alex del Priore, Senior VP at Syngene, for a fascinating conversation about their new site acquisition in Baltimore. It was great to hear Alex's insights on what this means for Syngene, the impact on their operations, capabilities and customers demand.

We really enjoyed discussing the values that drive such strategic decisions and how they align with Syngene's commitment to innovation and growth. If you’re curious about how companies like Syngene navigate these transformative changes, we invite you to check out the interview!

#syngene #leadership #acquisition #biotechnology #riskMmnagement #businessStrategy #pharmaceuticals

12 0

Don’t miss the opportunity to apply to present at the upcoming DCAT Summit in Lugano! This unique conference, titled Expedition Pharma: Innovation from a Patient-First Perspective, emphasizes that true innovation begins by understanding and prioritizing patient needs. The event will address significant industry challenges like global drug shortages, supply chain issues, drug pricing, sustainability, and the impact of AI—all focusing on enhancing patient care and outcomes.

It's an essential networking opportunity for C-suite executives, industry thought leaders, and decision-makers to connect and share groundbreaking strategies that align business objectives with patient-centric values.

Here is a message from Pierfrancesco Morosini President & CEO of Icrom Srl and DCAT board member.

0 0

Join us for this year's DCAT Lugano Summit and hear from Piero Poli, CEO of Rivopharm! Don't miss the opportunity to connect, learn, and elevate your professional journey.

Secure your spot today!

#DCATLuganoSummit #2025 #Rivopharm #pharmaceuticals #networking #innovation



Copy
Regenerate

2 0

We sat down with Stefano Togni, CCO of Indena, at DCAT Week! We explored Indena's role as a leading CDMO in the pharma industry, discussing their innovative approaches and commitment to quality. Exciting opportunities lie ahead as they continue to support pharmaceutical advancements!

#DCATWeek #Indena #pharma #CDMO #innovation

3 0

Here is a short clip featuring Kelsey Achenbach, VP of DSM-FIRMENICH, where she discusses the importance of attending this year’s DCAT Lugano Summit. Kelsey highlights the incredible networking opportunities, insights into industry trends, and invaluable knowledge sharing that attendees can expect.

It's a great chance to connect with peers and experts in our field.

0 0

Join us for our latest interview with Richard Johnson, Founder and Chief Scientific Officer of Upperton Pharma Solutions, where we dive deep into the company’s innovative services and exciting future plans. In this insightful conversation, Richard shares his vision for Upperton's role in the evolving landscape of the industry, highlighting their current offerings that are setting them apart from the competition.

We explore how Upperton is leveraging cutting-edge technology to enhance their services and what strategic initiatives are on the horizon. Tune in to discover Richard's perspective on the challenges and opportunities ahead, plus a glimpse into how Upperton aims to continue its legacy of excellence. Don’t miss this opportunity to learn more about a company that’s shaping the future!

0 0

At DCAT Week we caught up with Denis Angioletti, CCO at Cerbios SA.

This interview was recorded prior to the announcement that HAS - Healthcare Advanced Synthesis has acquired Cerbios SA. During our discussion, we explored investments, expansions, and future plans for Cerbios. There is no doubt that the joining of forces between HAS and Cerbios will leverage their strengths and create great opportunities for growth and innovation.

News available here: https://247biopharma.com/news/has-healthcare-advanced-synthesis-sa-acquires-cerbios-pharma-sa-to-create-leading-international-group-in-the-cdmo-sector-backed-by-65-equity-partners/

1 0